COMPANY |
agilon health, inc. |
COURT |
United States District Court for the Western District of Texas |
CASE NUMBER |
1:24-cv-00305 |
JUDGE |
TBD |
CLASS PERIOD |
April 15, 2021 through February 27, 2024 |
SECURITY TYPE |
Common Stock |
Case Background:
This is a class action on behalf of a class of all persons and entities who purchased or otherwise acquired agilon health, inc. (“agilon”) common stock between November 4, 2022, and January 4, 2024, inclusive (the “Class Period”).
The Complaint alleges that, throughout the Class Period, Defendants misled investors about agilon's medical costs by: (1) touting the Company's purported visibility into utilization trends and medical costs; (2) failing to disclose increased medical costs that agilon had incurred prior to and during the Class Period due to higher utilization of healthcare by MA patients; (3) falsely stating that its accounting reserves for higher-than-expected medical costs were adequate; (4) making false and misleading statements about the effectiveness of its business model; (5) issuing overly optimistic financial guidance; and (6) issuing risk disclosures that were materially false and misleading because they characterized adverse facts that had already materialized as mere possibilities.
Current Status of Case:
On June 6, 2024, the Court entered an Order consolidating related actions, appointing Lead Plaintiff and approving Lead Counsel. This action is ongoing.
If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Kessler Topaz Meltzer & Check, LLP: Jon Naji, Esq. (484) 270-1453; or via e-mail at info@ktmc.com.